Get started
Author

Agnieszka Kotecka-Blicharz

Observed names: A. Kotecka-Blicharz, Agnieszka Kotecka‐Blicharz, Agnieszka R. Kotecka‐Blicharz, Kotecka-Blicharz A, Kotecka-Blicharz, Agnieszka
ORCID: 0000-0002-8086-7346
Observed ORCID: 0000-0002-8086-7346
OpenAlex ID: A5007337086
Early Diagnosis of Low-Risk Papillary Thyroid Cancer Results Rather in Overtreatment Than a Better Survival
2020 · Jolanta Krajewska, Aleksandra Kukulska, et al. · Frontiers in Endocrinology · 88
PDF
Diagnosis and treatment of thyroid cancer in adult patients — Recommendations of Polish Scientific Societies and the National Oncological Strategy. 2022 Update [Diagnostyka i leczenie raka tarczycy u chorych dorosłych — Rekomendacje Polskich Towarzystw Naukowych oraz Narodowej Strategii Onkologicznej. Aktualizacja na rok 2022]
2022 · Barbara Jarząb, Marek Dedecjus, et al. · Endokrynologia Polska · 56
Rekomendacje Polskich Towarzystw Naukowych „Diagnostyka i leczenie raka tarczycy”. Aktualizacja na rok 2018
2018 · Barbara Jarząb, Marek Dedecjus, et al. · Endokrynologia Polska · 50
PDF
European perspective on the use of molecular tests in the diagnosis and therapy of thyroid neoplasms
2020 · Małgorzata Oczko-Wojciechowska, Agnieszka Kotecka-Blicharz, et al. · Gland Surgery · 24
PDF
Terapia radioizotopowa 131-MIBG złośliwych guzów chromochłonnych i przyzwojaków — badanie jednoośrodkowe
2018 · Agnieszka Kotecka-Blicharz, Kornelia Hasse-Lazar, et al. · Endokrynologia Polska · 14
PDF
Obraz kliniczny guzów chromochłonnych u nosicieli mutacji protoonkogenu RET — badanie jednoośrodkowe
2016 · Agnieszka Kotecka-Blicharz, Kornelia Hasse-Lazar, et al. · Endokrynologia Polska · 11
PDF
Differences in Gene Expression Profile of Primary Tumors in Metastatic and Non-Metastatic Papillary Thyroid Carcinoma—Do They Exist?
2020 · Sylwia Szpak-Ulczok, Aleksandra Pfeifer, et al. · International Journal of Molecular Sciences · 8
PDF
Bayesian Assessment of Diagnostic Strategy for a Thyroid Nodule Involving a Combination of Clinical Synthetic Features and Molecular Data
2020 · Aleksander Placzek, Alicja Pluciennik, et al. · IEEE Access · 8
PDF
Paragangliomas of the head and neck region
2018 · Paweł Polanowski, Agnieszka Kotecka-Blicharz, et al. · Nowotwory Journal of Oncology · 7
PDF
Polish diagnostic and therapeutic recommendations for adrenocortical carcinoma
2024 · Daria Handkiewicz-Junak, Marek Dedecjus, et al. · Endokrynologia Polska · 6
Only peak thyroglobulin concentration on day 1 and 3 of rhTSH-aided RAI adjuvant treatment has prognostic implications in differentiated thyroid cancer
2021 · Aleksandra Ledwon, Ewa Paliczka-Cieślik, et al. · Annals of Nuclear Medicine · 5
PDF
Clinical predictors of outcome in advanced adrenocortical carcinoma: a multicenter international ENSAT study
2026 · Alessandra Mangone, Barbara Altieri, et al. · European Journal of Endocrinology · 3
The role of thyroid sonographic malignancy risk features when the fine needle aspiration biopsy result is indeterminate
2022 · Agnieszka Kotecka-Blicharz, Marcela Krzempek, et al. · Endokrynologia Polska · 3
PDF
Thyroid nodules with indeterminate cytopathology: a constant challenge in everyday practice. The effectiveness of clinical decisions using diagnostic tools available in Poland
2021 · Agnieszka Kotecka-Blicharz, Aleksandra Pfeifer, et al. · Polskie Archiwum Medycyny Wewnętrznej · 3
PDF
Consolidation treatment with somatoatatin analogues after radiopeptide therapy
2014 · Aleksandra Sygula, Daria Handkiewicz-Junak, et al. · Endocrine Abstracts · 2
PDF
Germline Mutations in DNA Repair Genes in Patients with Pancreatic Neuroendocrine Neoplasms: Diagnostic and Therapeutic Implications
2025 · Beata Jurecka-Lubieniecka, Małgorzata Ros-Mazurczyk, et al. · Current Oncology · 1
PDF
38O Clinical predictors of treatment response in advanced adrenocortical carcinoma: A multicentre ENSAT study
2025 · A. Mangone, B. Altieri, et al. · ESMO Open · 1
PDF
Fibroblast growth factor 21 in patients with mild autonomic cortisol secretion and non-functioning adrenal incidentalomas
2024 · Lucyna Siemińska, Katarzyna Siemińska, et al. · Endokrynologia Polska · 1
PDF
Laparoscopic cortical-sparing adrenal surgery in pheochromocytomas associated with hereditary neoplasia syndromes
2020 · Kornelia Hasse-Lazar, Marcin Zeman, et al. · Endokrynologia Polska · 1
PDF
Long-term treatment with octreotide in a patient with malignant pheochromocytoma: impact on survival and time to tumor progression
2013 · Anna Gruszka, Wojciech Zieleniewski, et al. · Endocrine Abstracts · 1
Efficacy and safety of the CAPTEM regimen in patients with advanced adrenocortical carcinoma
2026 · Barbara Ziółkowska, Agnieszka Kotecka-Blicharz, et al. · Endocrine Connections
Clinical predictors of outcome in advanced adrenocortical carcinoma: a multicenter international ENSAT study
2026 · Mangone A, Altieri B, et al. · Yearbook of pediatric endocrinology
Succinate dehydrogenase (SDHB, SDHC, SDHD) gene variants significantly modify clinical outcomes in paraganglioma-pheochromocytoma but have a limited impact on head and neck paraganglioma
2026 · Jean-Pierre Bayley, Lauren Fishbein, et al. · Genetics in Medicine
OC7.1 - ECE_2484 - Pancreatic neuroendocrine neoplasms share germline DNA repair gene predisposition with breast, ovarian and colorectal cancer syndromes (BRCA2, CHEK2 and MMR)
2026 · Beata Jurecka-Lubieniecka, Malgorzata Ros-Mazurczyk, et al. · European Journal of Endocrinology
PDF
EP905 - ECE_3681 - The picture of adrenocortical carcinoma recurrence upon mitotane in adjuvant setting in a cohort from Central Europe Center
2026 · Agnieszka Kotecka-Blicharz, Kornelia Hasse-Lazar, et al. · European Journal of Endocrinology
PDF
Works count: 37
Citation count: 293
H-index: 8
I10-index: 6
Year
Topic
Type